nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0621	0.0968	CbGpPWpGaD
Cefdinir—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0396	0.135	CcSEcCtD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0311	0.0484	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0288	0.0449	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.02	0.0312	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0195	0.0304	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0186	0.0289	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0183	0.0285	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0183	0.0285	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0181	0.0282	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.017	0.0265	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.017	0.0265	CbGpPWpGaD
Cefdinir—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0576	CcSEcCtD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0139	0.0216	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.0129	0.0201	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0129	0.0201	CbGpPWpGaD
Cefdinir—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0435	CcSEcCtD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0124	0.0194	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.012	0.0186	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0116	0.018	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0115	0.0179	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0107	0.0166	CbGpPWpGaD
Cefdinir—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0362	CcSEcCtD
Cefdinir—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0091	0.031	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00894	0.0139	CbGpPWpGaD
Cefdinir—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0087	0.0296	CcSEcCtD
Cefdinir—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0294	CcSEcCtD
Cefdinir—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00852	0.029	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0083	0.0129	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00818	0.0127	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00818	0.0127	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00816	0.0127	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00759	0.0118	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00759	0.0118	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00746	0.0116	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00746	0.0116	CbGpPWpGaD
Cefdinir—SLC15A1—nephron tubule—nephrolithiasis	0.00744	0.116	CbGeAlD
Cefdinir—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0252	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0252	CcSEcCtD
Cefdinir—SLC15A1—renal system—nephrolithiasis	0.00676	0.105	CbGeAlD
Cefdinir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0226	CcSEcCtD
Cefdinir—SLC15A1—kidney—nephrolithiasis	0.00654	0.102	CbGeAlD
Cefdinir—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00637	0.0217	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0214	CcSEcCtD
Cefdinir—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00624	0.0212	CcSEcCtD
Cefdinir—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0212	CcSEcCtD
Cefdinir—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0211	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0062	0.00966	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0062	0.00966	CbGpPWpGaD
Cefdinir—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00617	0.021	CcSEcCtD
Cefdinir—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00615	0.0209	CcSEcCtD
Cefdinir—MPO—renal system—nephrolithiasis	0.00609	0.0945	CbGeAlD
Cefdinir—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00604	0.0205	CcSEcCtD
Cefdinir—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00591	0.0201	CcSEcCtD
Cefdinir—MPO—kidney—nephrolithiasis	0.00588	0.0913	CbGeAlD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00576	0.00898	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00576	0.00898	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00575	0.00896	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00575	0.00896	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00566	0.00881	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00566	0.00881	CbGpPWpGaD
Cefdinir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00537	0.0183	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00535	0.00833	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00535	0.00833	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00526	0.00819	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00526	0.00819	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00514	0.008	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0051	0.00794	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0051	0.00794	CbGpPWpGaD
Cefdinir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00487	0.0166	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00477	0.00743	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00473	0.00737	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00473	0.00737	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00469	0.0073	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00465	0.00725	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00465	0.00725	CbGpPWpGaD
Cefdinir—SLC15A2—nephron tubule—nephrolithiasis	0.00465	0.0722	CbGeAlD
Cefdinir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00455	0.0155	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00454	0.00708	CbGpPWpGaD
Cefdinir—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00443	0.0151	CcSEcCtD
Cefdinir—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0148	CcSEcCtD
Cefdinir—SLC15A2—renal system—nephrolithiasis	0.00423	0.0656	CbGeAlD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00422	0.00657	CbGpPWpGaD
Cefdinir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00421	0.0143	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00416	0.00647	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00416	0.00647	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00415	0.00646	CbGpPWpGaD
Cefdinir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00412	0.014	CcSEcCtD
Cefdinir—SLC15A2—kidney—nephrolithiasis	0.00409	0.0635	CbGeAlD
Cefdinir—SLC22A5—nephron tubule—nephrolithiasis	0.00405	0.0628	CbGeAlD
Cefdinir—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0137	CcSEcCtD
Cefdinir—SLC15A2—cortex of kidney—nephrolithiasis	0.00398	0.0618	CbGeAlD
Cefdinir—Shock—Hydrochlorothiazide—nephrolithiasis	0.00397	0.0135	CcSEcCtD
Cefdinir—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00395	0.0135	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00386	0.00601	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00386	0.00601	CbGpPWpGaD
Cefdinir—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00385	0.0131	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00379	0.00591	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00379	0.00591	CbGpPWpGaD
Cefdinir—SLC22A5—renal system—nephrolithiasis	0.00368	0.0571	CbGeAlD
Cefdinir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00365	0.0124	CcSEcCtD
Cefdinir—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00359	0.0122	CcSEcCtD
Cefdinir—SLC22A5—kidney—nephrolithiasis	0.00355	0.0552	CbGeAlD
Cefdinir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0121	CcSEcCtD
Cefdinir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00351	0.0119	CcSEcCtD
Cefdinir—SLC22A5—cortex of kidney—nephrolithiasis	0.00346	0.0538	CbGeAlD
Cefdinir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00345	0.0118	CcSEcCtD
Cefdinir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0033	0.0112	CcSEcCtD
Cefdinir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0109	CcSEcCtD
Cefdinir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0109	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00315	0.00491	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00315	0.00491	CbGpPWpGaD
Cefdinir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00297	0.0101	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00293	0.00456	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00293	0.00456	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00292	0.00455	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00292	0.00455	CbGpPWpGaD
Cefdinir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00986	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00287	0.00448	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00287	0.00448	CbGpPWpGaD
Cefdinir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00972	CcSEcCtD
Cefdinir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00276	0.0094	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00272	0.00423	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00272	0.00423	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00267	0.00416	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00267	0.00416	CbGpPWpGaD
Cefdinir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00909	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00261	0.00407	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00261	0.00407	CbGpPWpGaD
Cefdinir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00874	CcSEcCtD
Cefdinir—Rash—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00866	CcSEcCtD
Cefdinir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00866	CcSEcCtD
Cefdinir—Headache—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00861	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00242	0.00377	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00242	0.00377	CbGpPWpGaD
Cefdinir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00816	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00238	0.00371	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00238	0.00371	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00209	0.00325	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00194	0.00302	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0019	0.00297	CbGpPWpGaD
